drugset / Trial / NCT02952378

Volume Kinetics for Hyperoncotic Albumin in Burn Patients as Well as for Healthy Subjects

NCT02952378

Phase 4 Completed 30 enrolled University Hospital, Linkoeping
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Treatment with colloidal solutions has during long time been a cornerstone within intensive care. Lately, doubts have been raised about synthetic colloids, and the natural albumin has been used more and more. One of these solutions is the hyperoncotic "Albumin 20%". However there are still many aspects of the physiological effects of hyperoncotic albumin, that are not known. In this study physiological effects will be studied in burn patients and healthy subjects. The colloid osmotic pressure and the increase of the plasma volume will be measured in 15 healthy subjects and in 15 burn patients. The effect on the plasma volume will be studied using hemoglobin as a marker of dilution. Colloids osmotic pressure and albumin concentration will be measured directly and urin production will also be measured. Blood samples will be collected during 4 to 5 hours to achieve a profile over the changes.

Timeline

Start
2016-10
Primary completion
2019-01-31
Completion
2019-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Albumin Protein / enzyme biologic 3 unknown Intravenous

Indications

No indication recorded.